BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24363520)

  • 1. Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma.
    Wang J; Yang ZR; Dong WG; Zhang JX; Guo XF; Song J; Qiu S
    World J Gastroenterol; 2013 Dec; 19(45):8292-300. PubMed ID: 24363520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effect of sinomenine combined with 5-fluorouracil on colon carcinoma cell growth.
    Zhang JX; Yang ZR; Wu DD; Song J; Guo XF; Wang J; Dong WG
    Asian Pac J Cancer Prev; 2014; 15(16):6737-43. PubMed ID: 25169518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis.
    Guo B; Xie N; Wang Y
    Bull Cancer; 2015 Mar; 102(3):204-12. PubMed ID: 25747889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lapatinib inhibits the growth of esophageal squamous cell carcinoma and synergistically interacts with 5-fluorouracil in patient-derived xenograft models.
    Hou W; Qin X; Zhu X; Fei M; Liu P; Liu L; Moon H; Zhang P; Greshock J; Bachman KE; Ye BC; Wang H; Zang CY
    Oncol Rep; 2013 Aug; 30(2):707-14. PubMed ID: 23708506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer.
    Wang J; Yang ZR; Guo XF; Song J; Zhang JX; Wang J; Dong WG
    Mol Med Rep; 2014 Nov; 10(5):2535-41. PubMed ID: 25189132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation.
    Zhang C; Luo CL; Shang GS; Jiang DX; Song Q
    Med Sci Monit; 2021 Dec; 27():e931630. PubMed ID: 34916479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Carotene synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal squamous cell carcinoma in vivo and in vitro.
    Zhang Y; Zhu X; Huang T; Chen L; Liu Y; Li Q; Song J; Ma S; Zhang K; Yang B; Guan F
    Toxicol Lett; 2016 Nov; 261():49-58. PubMed ID: 27586268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
    Tian F; Zhang C; Tian W; Jiang Y; Zhang X
    Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
    Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
    Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C; Guo LB; Ma JY; Li YM; Liu HM
    Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma.
    Hu XY; Liang JY; Guo XJ; Liu L; Guo YB
    Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells.
    Ren K; Zhang W; Wu G; Ren J; Lu H; Li Z; Han X
    Biomed Pharmacother; 2016 Dec; 84():1748-1759. PubMed ID: 27876206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio.
    Du L; Fei Z; Song S; Wei N
    Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/AKT1 Signaling Pathway Mediates Sinomenine-Induced Hepatocellular Carcinoma Cells Apoptosis: An in Vitro and in Vivo Study.
    Luo Y; Liu L; Zhao J; Jiao Y; Zhang M; Xu G; Jiang Y
    Biol Pharm Bull; 2022; 45(5):614-624. PubMed ID: 35491166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
    Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
    Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics.
    Zhang C; Ma Q; Shi Y; Li X; Wang M; Wang J; Ge J; Chen Z; Wang Z; Jiang H
    Oncol Rep; 2017 May; 37(5):2942-2954. PubMed ID: 28393186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
    Xu GY; Tang XJ
    Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
    J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.